Back to search

Article

Detection of aberrantly methylated tumor suppressor genes in breast cancer patients as a potential diagnostic biomarker

2021-04-09

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Aberrant methylation of tumor suppressor genes is a common feature of breast cancer. Identifying a panel of methylated genes that are sensitive and specific for breast cancer could help to diagnose and predict prognosis of breast cancer.<bold>Methods: </bold>We determined the methylation status of DACT1, PAX5, PLCD1, ZNF545 and TET1 in 32 benign controls, 237 ca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
16964135-5d18-5af2-a8df-c01902fdf069
DOI
10.21203/rs.3.rs-327347/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Detection of aberrantly methylated tumor suppressor genes in breast cancer patients as a potential diagnostic biomarkerDOI 10.21203/rs.3.rs-327347/v1
Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancerSemantic proximity
Detection of biomarkers related to the diagnosis and prognosis of breast cancer through the combination of gene expression profiling and DNA methylationSemantic proximity
Statistical analysis of DNA methylation patterns of tumor suppressor genes for breast cancerSemantic proximity
Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screenSemantic proximity
Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.Semantic proximity
Identification of a DNA Methylation-Driven Genes-Based Prognostic Model and Drug Targets in Breast Cancer: In silico Screening of Therapeutic Compounds and in vitro Characterization.Semantic proximity
Aberrant Methylation Status of Tumour Suppressor Genes in Ovarian Cancer Tissue and Paired Plasma SamplesSemantic proximity
Downregulated ZNF132 Predicts Unfavorable Outcomes in Breast Cancer via Hypermethylation ModificationSemantic proximity
In silico analysis of differentially expressed-aberrantly methylated genes in breast cancer for prognostic and therapeutic targetsSemantic proximity
The Role of Methylation in Breast Cancer Susceptibility and Treatment.Semantic proximity
Bromodomain containing 4 (BRD4) as a potential prognostic marker in a pan-cancer analysis of human tumorsSemantic proximity
Pan-cancer analyses reveal molecular and clinical characteristics of TET family members and suggests that TET3 maybe a potential therapeutic targetSemantic proximity
Select a neighboring publication to make it the new centre.